Key Takeaway
Seven FKRP diagnoses among 87 people evaluated for LGMD illustrate the value of molecular confirmation when clinical presentations overlap.
Evidence Summary
A genetic screening study identifying FKRP-related LGMD in two North American referral cohorts.
Citation: Kang PB, Feener CA, Estrella E, et al. LGMD2I in a North American population. BMC Musculoskelet Disord. 2007;8:115.
Key Takeaway
Seven FKRP diagnoses among 87 people evaluated for LGMD illustrate the value of molecular confirmation when clinical presentations overlap.
Primary Sources
Primary indexed record for the paper summary on this page.
Publisher DOI landing page.
Related Content
Paper Summary
Review article mapping FKRP biology, disease mechanisms, model systems, and the treatment approaches that were emerging by 2021.
Glossary
The relationship between a genetic variant pattern and the clinical features seen in a person or group.
Guide
FKRP is a gene involved in alpha-dystroglycan glycosylation. Pathogenic variants in FKRP can cause a spectrum of muscular dystrophy-dystroglycanopathies, ranging from severe congenital presentations to later-onset limb-girdle disease.